Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients


This is an observational pilot study focused on collecting data on clinical variables that can improve the understanding of potential predictors of disease exacerbation and readmissions in COPD patients. The study aim is to understand how the variability of clinical parameters (respiratory rate, forced expiratory volume in one second, and oxygen saturation), physical activity and quality of life is associated with the risk of exacerbation in COPD patients.

Study Start Date

December, 01 2016

Estimated Completion Date

May 2018


No interventions cited

Study ID

Massachusetts General Hospital -- 2016P002312



Trial ID


Study Type


Trial Phase


Enrollment Quota



Massachusetts General Hospital

Inclusion Criteria

    1. Medically stable and ambulatory COPD (primary diagnosis) patients who have had an emergency room visit or hospitalization for an acute exacerbation of COPD within the past 30 days. 2. Sufficient understanding of the English language to be able to read and understand study procedures.

Exclusion Criteria

    1. Currently on admission in the hospital, on non-invasive positive airway pressure ventilation 2. Visual, hearing or cognitive impairments at the discretion of their physician. 3. Currently participating in a COPD telemonitoring program. 4. No AT&T cellular coverage at their primary residence 5. Any other medical or psychological condition that, in the opinion of the investigator may present an unreasonable risk to the study participant as a result of his/her participation in this study, may make participant's participation unreliable, or may interfere with study assessments.




18 Years and older

Accepts Healthy Volunteers


Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Partners Connected Health - Boston, Massachusetts 2.8 miles Yunmi Shin 617-643-0198 provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.